recombinanat viral vector vaccine CEPI/University of Tokyo

N/A

Report date: 2025/03/20 09:38:17

Base Information

Drug Namerecombinanat viral vector vaccine CEPI/University of Tokyo
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHenipavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNorwayJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCoalition for Epidemic Preparedness Innovations
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of TokyoCoalition for Epidemic Preparedness Innovations
Inactive CompaniesN/A
Active IndicationsHenipavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A